Home
News
Media
All VideosClinical Trials in ProgressImmunoLogicNews Network
Partners
More
CME/CE
Conferences
Sponsored

Subscribe

  • Home
  • News
  • Media
  • Partners
  • CME/CE
  • Conferences
  • Sponsored
  • Subscribe
  • Cardiology
  • Dermatology
  • Endocrinology
  • Hematology
  • Lysosomal Disorders
  • Neurology
  • Oncology
  • Ophthalmology
Advertisement

Ian Miller, MD

Advertisement

Articles by Ian Miller, MD

Ian Miller, MD: Adapting AAV Gene Therapy for SCN1A-Positive Epilepsy

ByIan Miller, MD
December 17th 2019

The medical director of the Comprehensive Epilepsy Clinic at Nicklaus Children’s Hospital discusses his early stage gene therapy trial for Dravet syndrome.

Advertisement

Latest Updated Articles

  • Ian Miller, MD: Adapting AAV Gene Therapy for SCN1A-Positive Epilepsy
    Ian Miller, MD: Adapting AAV Gene Therapy for SCN1A-Positive Epilepsy

    Published: December 17th 2019 | Updated:



Advertisement
Advertisement

Trending on CGTlive®

1

Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial

2

Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025

3

Guess the Therapy Answer October 16, 2025

4

Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation

5

Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years

  • About Us
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Do Not Sell My Information
  • Privacy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • HCP Live
  • Contagion Live
  • CGT Live
  • Neurology Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
HCP Live
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us